Use of (+)-alpha - (2,3-dimethoxyphenyl)-1-(2-(4-fluoroph enyl)ethyl)-4piperidinemerthanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis

Details for Australian Patent Application No. 2001264842 (hide)

International Classifications

Event Publications

27 January 2005 Application Accepted

Published as AU-B-2001264842

26 May 2005 Standard Patent Sealed

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.